Total Payments
$26,442
2024 Payments
$6,639
Companies
3
Transactions
24
Payment Breakdown by Category
Other$21,755 (82.3%)
Consulting$3,760 (14.2%)
Travel$628.70 (2.4%)
Food & Beverage$298.14 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,700 | 14 | 70.7% |
| Consulting Fee | $3,760 | 2 | 14.2% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,645 | 1 | 6.2% |
| Honoraria | $1,410 | 2 | 5.3% |
| Travel and Lodging | $628.70 | 2 | 2.4% |
| Food and Beverage | $298.14 | 3 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Global Blood Therapeutics, Inc. | $19,740 | 17 | $0 (2022) |
| PFIZER INC. | $6,639 | 6 | $0 (2024) |
| American National Red Cross | $63.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,639 | 6 | PFIZER INC. ($6,639) |
| 2022 | $3,055 | 3 | Global Blood Therapeutics, Inc. ($3,055) |
| 2021 | $8,695 | 7 | Global Blood Therapeutics, Inc. ($8,695) |
| 2020 | $7,990 | 7 | Global Blood Therapeutics, Inc. ($7,990) |
| 2018 | $63.00 | 1 | American National Red Cross ($63.00) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $199.50 | General |
| Category: HEMATOLOGY | ||||||
| 09/18/2024 | PFIZER INC. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: HEMATOLOGY | ||||||
| 09/12/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HEMATOLOGY | ||||||
| 05/09/2024 | PFIZER INC. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| Category: HEMATOLOGY | ||||||
| 05/07/2024 | PFIZER INC. | OXBRYTA (Drug) | Travel and Lodging | In-kind items and services | $429.20 | General |
| Category: HEMATOLOGY | ||||||
| 05/07/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $110.14 | General |
| Category: HEMATOLOGY | ||||||
| 09/28/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Honoraria | Cash or cash equivalent | $940.00 | General |
| Category: Sickle Cell Disease | ||||||
| 03/08/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Honoraria | Cash or cash equivalent | $470.00 | General |
| Category: Sickle Cell Disease | ||||||
| 01/08/2022 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,645.00 | General |
| Category: Sickle Cell Disease | ||||||
| 10/14/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $470.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 09/30/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Consulting Fee | Cash or cash equivalent | $3,290.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 04/22/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 04/08/2021 | Global Blood Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $587.50 | General |
| 03/19/2021 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $822.50 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 02/17/2021 | Global Blood Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $705.00 | General |
| 02/13/2021 | Global Blood Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,880.00 | General |
| 11/12/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $705.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 11/10/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 09/17/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 08/11/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $940.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/09/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $705.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/06/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,880.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 06/03/2020 | Global Blood Therapeutics, Inc. | OXBRYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,880.00 | General |
| Category: SICKLE CELL DISEASE | ||||||
| 03/29/2018 | American National Red Cross | — | Food and Beverage | Cash or cash equivalent | $63.00 | General |
About Dr. Astrid Mack, MD
Dr. Astrid Mack, MD is a Pediatric Hematology-Oncology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700948643.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Astrid Mack, MD has received a total of $26,442 in payments from pharmaceutical and medical device companies, with $6,639 received in 2024. These payments were reported across 24 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,700).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Chicago, IL
- Active Since 12/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1700948643
Products in Payments
- OXBRYTA (Drug) $23,206
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Chicago
Alexis Thompson, Md, MD
Pediatric Hematology-Oncology — Payments: $1.6M
Pediatric Hematology-Oncology $1.6M
James Labelle
Pediatric Hematology-Oncology — Payments: $249,251
Pediatric Hematology-Oncology $249,251
Sherif Badawy, Md, MD
Pediatric Hematology-Oncology — Payments: $207,866
Pediatric Hematology-Oncology $207,866
Dr. Loretta Li, M.d, M.D
Pediatric Hematology-Oncology — Payments: $187,559
Pediatric Hematology-Oncology $187,559
Susan Cohn
Pediatric Hematology-Oncology — Payments: $125,685
Pediatric Hematology-Oncology $125,685
Leonard Valentino, M.d, M.D
Pediatric Hematology-Oncology — Payments: $117,453
Pediatric Hematology-Oncology $117,453